Description
A VEGFR inhibitor (IC50s = 1.2, 0.25, and 0.29 nM for VEGFR1, -2, and -3, respectively); inhibits c-Kit and PDGFRβ (IC50s = 1.7 and 1.6 nM, respectively); inhibits VEGF-induced migration of and tube formation by HUVECs; reduces microvessel density, a marker of angiogenesis, and tumor growth in MV522 colon carcinoma, A375 melanoma, SN12C GFP renal carcinoma, and U87 glioma mouse xenograft models from 1-100 mg/kg
Formal name: N-methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]-benzamide
Synonyms: AG-013736
Molecular weight: 386.5
CAS: 319460-85-0
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|PDGFR Family||Product Type|Biochemicals|Kinase Inhibitors|VEGFR Family||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Angiogenesis||Research Area|Cancer|Cell Signaling|Growth Factor Receptor Signaling